Icos and Texas Biotechnology enter joint venture to develop and commercialize endothelin antagonists June 13, 2000
Combined AT1 blockade/ACE inhibition reduces blood pressure, protects kidney in CALM study June 6, 2000
INSIGHT study establishes once-daily Adalat as first-line therapy for higher risk hypertension June 5, 2000
RSS